Acute kidney injury (AKI), resulting from a variety of etiologies, is a frequent medical diagnosis identified in hospitalized patients. AKI precipitates an abrupt decrease in kidney function that leads to an accumulation of extracellular fluid, urea, and other nitrogenous waste products, along with the dysregulation of electrolytes. Moreover, the diagnosis of AKI portends worse short-term and long-term outcomes and is associated with the consumption of greater healthcare resources1. According to the United States Renal Data System (USRDS), among Medicare Fee-For-Service beneficiaries in 2020, the rate of hospitalization with AKI was 62 admissions per 1000 patient years2. Furthermore, a systematic review of 154 studies that adopted the Kidney Disease Improving Global Outcomes (KDIGO) AKI diagnostic criteria found that among the 3,585,911 people in these trials, primarily from North America, Northern Europe, and Eastern Asia, the incidence of AKI in different inpatient settings ranged from 20%-32%3. In the inpatient setting, AKI is commonly identified in the intensive care unit and is associated with increased mortality4. Point-of-care ultrasound (POCUS) machines are readily available in settings such as the ICU, but diagnostic kidney-GU ultrasound is often underused despite being able to quickly evaluate several etiologies of AKI5.
Compared to consultative ultrasound, in which a patient's primary provider orders a formal ultrasound to be performed by a radiology technician and read by a radiologist, diagnostic POCUS is performed and interpreted by a patient's primary provider at the point of care6. There is growing evidence that non-radiologists can effectively and accurately use diagnostic POCUS for a variety of conditions7. For instance, the 2019 Hospitalist-Operated Compression Ultrasonography: a Point-of-Care Ultrasound Study (HOCUS-POCUS) prospective cohort study compared hospitalist-performed deep vein thrombosis (DVT) compressive POCUS to consultative technician/radiologist performed vascular DVT ultrasound. The study showed similar accuracy of hospitalist-performed POCUS to technician/radiologist-performed consultative vascular ultrasound with sensitivity of 100% and specificity of 96%8. Similarly, a 2020 study found kidney-GU POCUS performed by Emergency Department providers of varied experience had moderate accuracy (specificity of 72% and sensitivity of 77%) in detecting hydronephrosis when compared to computed tomography scan9. Importantly, primary-provider performed POCUS allows for more timely diagnosis and intervention compared to technician/radiologist imaging.
Causes of AKI can be divided into pre-renal (hemodynamically mediated injury), intra-renal (glomerular or interstitial pathologies), and post-renal (urologic etiologies, most commonly obstructive uropathy). The latter, especially, can be diagnosed with POCUS. Obstructive uropathy has an annual incidence of 1.7 per 1000 people and has been estimated to account for about 10% of acute and chronic kidney disease10. From prostatic hyperplasia to nephrolithiasis, there are many causes of urinary obstruction. The main pathologic manifestation of these conditions at the level of the kidney is hydronephrosis. This is easily visualized on POCUS, and speed in diagnosis can be critical in treating acutely ill patients with kidney failure.
Beyond AKI, POCUS remains a cost-effective and safe modality for evaluating chronic kidney disease. POCUS can be used to identify lesions indicative of renal cell carcinoma, given the ability to visualize cysts greater than or equal to 3 cm and to discriminate characteristics deemed concerning for malignancy11. POCUS allows for the rapid evaluation of autosomal dominant polycystic kidney disease (ADPKD), avoiding unnecessary scheduling of kidney biopsies and expensive lab work. Additionally, ultrasonographic measurement of kidney length was shown to prognosticate risk of progression in early ADPKD when compared to the gold standard magnetic resonance-based, height-adjusted total kidney volume measurement (htTKV)12.
While computed tomography scans have an advantage in detecting neoplasms, stones, and calcifications, there has been no proven benefit of computed tomography over ultrasonography in the diagnosis of AKI etiologies13. Furthermore, some patients may be too sick to move out of their rooms, precluding transport to the CT scanner or even the radiology suite for a technician/radiologist to perform the consultative ultrasound. In these cases, POCUS provides a safe and reliable diagnostic alternative. Despite this, diagnostic kidney-GU POCUS remains an underused tool, likely due to a lack of training among frontline clinicians14. To address this knowledge gap, this narrative review brings together the expertise of multiple specialties (hospital medicine, critical care, anesthesiology, and nephrology) to propose an evidence-based kidney-GU POCUS image acquisition protocol, including indications/contraindications, patient positioning, transducer selection, acquisition sequence, and exam limitations. Finally, we describe foundational concepts in kidney-GU ultrasound image interpretation, including key abnormal findings that every bedside clinician performing this modality should know.